Get started

Volumespreadanalysis

$SMMT Next Target PT 2 and higherSummit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. It also offers SMT-738, for combating multidrug resistant infections primarily carbapenem-resistant Enterobacteriaceae infections; and DDS-04 series for the potential treatment of infections caused by the Enterobacteriaceae. The company was founded in 2003 and is based in Cambridge, Massachusetts.
NASDAQ:SMMTLong
by BADQOMOCAWGOWLD
$INDO Next Target PTs 18-30 and higherIndonesia Energy Corporation Limited operates as an oil and gas exploration and production company in Indonesia. It holds interests in the Kruh Block, a producing block covering an area of 258 square kilometers with net crude oil proved reserves of 1.52 million barrels located to the northwest of Pendopo, Pali, South Sumatra; and the Citarum Block, an exploration block covering an area of 3,924.67 square kilometers located onshore in West Java. The company was incorporated in 2018 and is headquartered in Jakarta, Indonesia. Indonesia Energy Corporation Limited is a subsidiary of Maderic Holding Limited.
AMEX:INDOLong
by BADQOMOCAWGOWLD
1
$NEPT Next Target PTs 5.50-6 and higherNeptune Wellness Solutions Inc. operates as an integrated health and wellness company in Canada, the United States, and internationally. It builds a portfolio of lifestyle brands and consumer packaged goods products under the Biodroga, Forest Remedies, Ocean Remedies, Neptune Wellness, Mood Ring, PanHash, Sprout, Nosh, MaxSimil, and NurturMe brands. The company also offers turnkey product development and supply chain solutions to business customers in various health and wellness verticals, including nutraceuticals, beauty and personal care products, and organic foods and beverages. In addition, it is involved in the extraction, purification, formulation, and manufacturing of health and wellness products. Further, the company offers Maxsimil, an omega-3 fatty acid delivery technology that uses enzymes that mimic the natural human digestive system to predigest omega-3 fatty acids. It has a collaboration agreement with International Flavors & Fragrances Inc. to co-develop hemp-derived CBD products for the mass retail, and health and wellness markets. The company was incorporated in 1998 and is headquartered in Laval, Canada.
NLong
by BADQOMOCAWGOWLD
$QTNT Next Target PT .50 and higherQuotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology, serological disease screening, and molecular disease screening. Its conventional reagent products for blood grouping include antisera products that are used to identify blood group antigens; reagent red blood cells, which enable the identification of blood group antibodies; whole blood control products for use as daily quality assurance tests; and ancillary products that are used to support blood grouping. The company also offers MosaiQ SDS Microarray that is designed as a serological disease screening microarray comprised assays to detect cytomegalovirus and Syphilis; MosaiQ MDS Microarray that is designed as a molecular disease screening microarray test for donor red cells or source plasma; MosaiQ IH Microarray as a blood grouping microarray; MosaiQ Autoimmune Microarray; MosaiQ COVID-19; and MosaiQ IH3 Microarray. It sells its products to hospitals, donor collection agencies, independent testing laboratories, original equipment manufacturers, and blood banking operation and other diagnostics companies. Quotient Limited was founded in 2007 and is headquartered in Eysins, Switzerland.
QLong
by BADQOMOCAWGOWLD
$ENSV entry PTs 1.66-1.80 Next Target PT 10 and higher Enservco Corporation, through its subsidiaries, provides well enhancement and fluid management services to the onshore oil and natural gas industry in the United States. It offers frac water heating, hot oiling, pressure testing, acidizing, and water hauling, as well as well site construction services. The company owns and operates a fleet of approximately 318 specialized trucks, trailers, frac tanks, and other well-site related equipment. It operates in the eastern United States region comprising the southern region of the Marcellus Shale formation and the Utica Shale formation in eastern Ohio; Rocky Mountain region consisting of western Colorado and southern Wyoming, central Wyoming, western North Dakota, and eastern Montana; and the Central United States region, including Eagle Ford Shale and East Texas Oilfield in Texas. Enservco Corporation was incorporated in 1980 and is headquartered in Longmont, Colorado.
ELong
by BADQOMOCAWGOWLD
$IMPP entry PTs .35-.40 Next Target PTs .45-.90 and higher Long Imperial Petroleum Inc. provides international seaborne transportation services to oil producers, refineries, and commodities traders. It carries refined petroleum products, such as gasoline, diesel, fuel oil, and jet fuel, as well as edible oils and chemicals; and crude oils. As of March 29, 2022, the company owned four medium range refined petroleum product tankers and one Aframax crude oil tanker with a total capacity of 305,804 deadweight tons. The company was incorporated in 2021 and is based in Athens, Greece.
NASDAQ:IMPPLong
by BADQOMOCAWGOWLD
$DRUG Next Target PTs 4.50-9 and higherBright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry. The company has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. The company was incorporated in 2019 and is headquartered in Vancouver, Canada.
NASDAQ:DRUGLong
by BADQOMOCAWGOWLD
$HSDT Next Target PTs 2.25-2.75 and higherHelius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.
NASDAQ:HSDTLong
by BADQOMOCAWGOWLD
ILMN - Inverse Head & Shoulders Looking the huge volume accumulation in the last 3 days, there is a chance that ILMN is going to breakout of an inverse H&S neckline soon. So let's watch! If it does break up, it should not retrace below the neckline again (if it does, consider this a failed inverse H&S). Theoretical inverse H&S targe @ 308 (which incidentally is also the 38% fibonacci retracement of it's peak to bottom swing (AB) Manage positions with trailing stops Disclaimer: Just my 2 cents and not a trade advice. Kindly do your own due diligence and trade according to your own risk tolerance and don't forget that money management is important! Take care and Good Luck!
NASDAQ:ILMN
by Juliac
1
E-MINI S&P500'S SEARCH FOR VALUE15TH OF AUGUST – 1ST ENTRY (ES Futures Contract) I started to build my swing position by shorting the market at 4275.00. At the moment I’m risking 0.25%. I’m 25 points away from my entry targets. The reasons for an early entry are: 1. Overall weak Market Structure (last 2 month-rally). 2. Weak liquidity on 4 Consecutive Days. This is suggesting me that we might be experiencing a temporary bullish hype by weak hand traders. 3. Gradual build up of my trade. A market that trades against me and goes to 4300 and beyond will allow me to add more size and complete the trade, while improving my average price of entry. NOTES 4100 – 4150 = it is logical for the market to trade in brackets around a high-volume area, which in this case it was also the fairest price of the instrument (VPOC). The most important aspect of monitoring the VPOC (volume point of control) or fairest price level is the ability to visualise the potential change or no change in the fairest price level. On the 10th of August the market breaks away in an attempt to raise the perceived value of the S&P500. 11th of August – Perfect example of how the markets lie and trading what you see can be dangerous. The daily candle closed as a shooting star and trapped many traders into weak positions making them think it was a possible turning point. I was suspicious due to weak liquidity been put into the market and various volume anomalies. On the next day we have the shooting start violation and therefore a market confirming the fact that we didn’t have any real selling pressure that day, but rather a liquidation due to profit taking of weak hands traders. 4300 – 4365 = This is the area of potential entries. The value of the instrument is out of balance once again, the market can now be attracted to this area where we have significant low volume nodes. Low volume nodes represent past aggressive auctions (aggressive sellers here) which take the market out of fair value. They tend to be rebalanced by the market at some point, just like any other weak/inefficient area. At 4300 we also have obvious/weak highs. Any buying that took place above the fairest price level (VPOC) saw buyers buying price above the fairest price. When this is occurring traders are taking above-average risk , when I trade I like to constantly think in terms of odds. Any selling, relative to the fairest price level, would be considered selling short-in-the-hole or selling price below value. In other words, by going out of balance now (breaking away from the VPOC) we are testing the best short locations. This becomes particularly powerful when contextualised in a particular scenario (like this case) and compared with volume in relation to time and price, market structure and other relevant clues. For more explanations, please view my previous post, "A Dive Into My Swing Trading Approach (+setup)".
CME_MINI:ES1!Short
by LionLazzari
EURUSD BEAR OR BULL BREAK?Pair: EURUSD Timeframe: 4H Analysis: Round number level, trend line, volume profile, support and resistance, ascending wedge pattern ————— Key Takeaway: Need to see break of this ascending triangle to the down or up side depending on the US Core Inflation rate we see tomorrow ————— Level needed: Upside: 1.20845 downside: 1.01955 - 1.01848 ————— Trade: Neutral RISK:REWARD — SL: — TP: — ————— DO NOT ENTER OUR SETUPS WITHOUT CONFIRMATION
by TheGoldRoom
U - breakout soon?After hitting the low on 11 May, U traded in a sideway range between 32-48 for almost 3 months now, forming a possible base. The higher volume during this period suggest there could be some accumulation going on. However with earnings expected out tomorrow, there is a always risk of a nasty surprise. Hence to be conservative, wait for results to be out. Should the stock rise after earnings, buy near the break or wait for the first pullback. Disclaimer: Just my 2 cents and not a trade advice. Kindly do your own due diligence and trade according to your own risk tolerance and don't forget that money management is important! Take care and Good Luck!
NYSE:U
by Juliac